Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Interest Expenses (2010 - 2025)

Grifols' (GIFLF) quarterly Interest Expenses came in at -$727527.2 in Q4 2025, up 4.65% on a YoY basis from -$695225.2 in Q4 2024, and up 4.65% quarter-over-quarter from -$762977.1 in Q4 2024.

Analysis

Grifols (GIFLF) Interest Expenses (2010 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Interest Expenses for 15 consecutive years, with -$727527.2 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses rose 4.65% year-over-year to -$727527.2; the trailing twelve-month figure through Dec 2025 stood at $79.4 million (down 45.54% YoY), and the FY2025 full-year result was -$706.1 million, up 7.45% from the prior year.
  • Interest Expenses improved to -$727527.2 in Q4 2025 per GIFLF's latest filing, from -$762977.1 in the prior quarter.
  • Across five years, Interest Expenses topped out at $81.5 million in Q4 2021 and bottomed at -$762977.1 in Q4 2024.
  • Historically, Interest Expenses has averaged $19.9 million across 4 years, with a median of -$684931.7 in 2023.
  • The sharpest annual moves came in 2021 and 2024: Interest Expenses gained 24.18% in 2021, then slipped 18.78% in 2024.
  • Over 4 years, Interest Expenses stood at $81.5 million in 2021, then slumped by 100.79% to -$642336.1 in 2023, then retreated by 18.78% to -$762977.1 in 2024, then grew by 4.65% to -$727527.2 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods registered -$727527.2, -$762977.1, and -$642336.1 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 673.00 Mn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 247.00 Mn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 11.00 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -1.00 Mn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn 82.05 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -727,527.20
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -727,527.20
Dec 31, 2024 -762,977.12
Dec 31, 2023 -642,336.13
Dec 31, 2021 81.54 Mn
Dec 31, 2020 65.66 Mn
Dec 31, 2019 65.38 Mn
Dec 31, 2018 -334.74 Mn
Jun 30, 2018 -247.31 Mn
Dec 31, 2017 -310.07 Mn
Jun 30, 2017 76.41 Mn
Dec 31, 2016 -64.32 Mn
Sep 30, 2016 68.29 Mn
Jun 30, 2016 71.44 Mn
Dec 31, 2015 52.46 Mn
Sep 30, 2015 67.25 Mn
Jun 30, 2015 64.73 Mn
Mar 31, 2015 -68.65 Mn
Dec 31, 2014 74.88 Mn
Sep 30, 2014 71.27 Mn
Jun 30, 2014 73,016.50